Impact of Dupilumab Therapy on Skin Barrier Function in Patients With Moderate-to-Severe Atopic Dermatitis: A Phase IV, Non-Randomized, Open-Label, Parallel-Group Clinical Study.
Overview & Synopsis
Open access biomedical research article published in MedComm (2020).
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Impact of Dupilumab Therapy on Skin Barrier Function in Patients With Moderate-to-Severe Atopic Dermatitis: A Phase IV, Non-Randomized, Open-Label, Parallel-Group Clinical Study. |
|---|---|
| Author / Organization | Liu T, Chen S, Zhao W, Di D, Liu J, Tian Y, Luo Y, Xu Y, Xue R, Ye L, Pei X, Yu B, Wang Y, Zhang J, Yu X, Wen W, Yuan L, Ji S, Hu C, Shen D, Guo Y, Liang Y |
| Subject & Discipline | MedComm (2020) |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-3727 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |